The value of hemoglobin-to-red blood cell distribution width ratio (Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer

被引:21
|
作者
Lin, Zhongyuan [1 ]
Zhang, Xuan [2 ]
Luo, Yu [1 ]
Chen, Yanyun [1 ]
Yuan, Yulin [1 ]
机构
[1] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Clin Lab, Nanning, Guangxi Zhuang, Peoples R China
[2] Guangxi Med Univ, Dept Nucl Med, Affiliated Hosp 1, Nanning, Guangxi Zhuang, Peoples R China
关键词
hemoglobin-to-red blood cell distribution width; nasopharyngeal cancer; neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; CARCINOMA; INCREASE; STATISTICS; EXPRESSION;
D O I
10.1097/MD.0000000000026537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The clinical significance of hemoglobin-to-red blood cell distribution width (Hb/RDW) for the diagnosis of nasopharyngeal cancer (NPC) has not been reported yet. This study aimed to evaluate the value of preoperative Hb/RDW, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of NPC. A total of 180 NPC patients (NPC group) and 149 healthy subjects (control group) were recruited to assess the value of Hb/RDW, NLR, and PLR for the diagnosis of NPC. It was noted that NLR and PLR were significantly higher in the NPC group than those in the control group (P < .001); however, Hb/RDW was lower in the NPC group compared with that in the control group (P < .001). NLR was also remarkably different between patients of stage I+II and those of stage III+IV (P = .043), and that was different in patients with lymph node metastases or not (P = .030). Besides, PLR was significantly different in patients with serosal invasion or not (P = .031). In receiver operating characteristic curve, compared with Hb/RDW alone (sensitivity, 66.67%; specificity, 85.23%), the sensitivity (67.78%, 72.78%) and specificity (89.62%, 90.6%) of Hb/RDW with NLR and PLR were both increased. Furthermore, Hb/RDW combined with NLR area under the ROC (AUC), 0.824; 95% confidence interval (CI): 0.779-0.864, P = .0080) or PLR (AUC: 0.851, 95% CI: 0.808-0.888, P = .0002) had a greater AUC value for the diagnosis of NPC compared with Hb/RDW alone (AUC: 0.781, 95% CI: 0.732-0.824). Hb/RDW can be used as a valuable indicator for auxiliary diagnosis of NPC. Preoperative Hb/RDW combined with NLR or PLR is of great significance in the auxiliary diagnosis and pathological staging of NPC.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Dynamics of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), and Platelet-to-Lymphocyte Ratio (PLR) in Patients with Deep Neck Infection
    Kim, Jeong-Mi
    Hoang, Huu
    Choi, Jeong-Seok
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [22] Evaluation of platelet-to-lymphocyte ratio, red cell distribution width and neutrophil-to-lymphocyte ratio as potential biomarkers in the early detection of gastric cancer
    Cakmak, Erol
    Altinkaya, Engin
    Acibucu, Fettah
    Yonem, Ozlem
    Yilmaz, Abdulkerim
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (03): : 6687 - 6692
  • [23] The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer
    Maloney, Sarah
    Pavlakis, Nick
    Itchins, Malinda
    Arena, Jennifer
    Mittal, Anubhav
    Hudson, Amanda
    Colvin, Emily
    Sahni, Sumit
    Diakos, Connie
    Chan, David
    Gill, Anthony J.
    Samra, Jaswinder
    Clarke, Stephen J.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (05)
  • [24] Correlation of clinical signs and symptoms of Behcet's disease with platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR)
    Shadmanfar, Soraya
    Masoumi, Maryam
    Davatchi, Fereydoun
    Shahram, Farhad
    Akhlaghi, Maassoumeh
    Faezi, Seyedeh Tahereh
    Kavosi, Hoda
    Parsaei, Amirhossein
    Moradi, Soroush
    Balasi, Javad
    Moqaddam, Zeynab Rastgar
    IMMUNOLOGIC RESEARCH, 2021, 69 (04) : 363 - 371
  • [25] Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC)
    Vitorino, M.
    Tomas, T.
    Almeida, S.
    Silva, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S793 - S794
  • [26] Can Platelet-to-Lymphocyte Ratio (PLR) and Neutrophil-to-Lymphocyte Ratio (NLR) Help Predict Outcomes of Patients With Recurrent Glioblastoma?
    Zemskova, Oksana
    Yu, Nathan Y.
    Leppert, Jan
    Loeser, Anastassia
    Rades, Dirk
    IN VIVO, 2024, 38 (05): : 2341 - 2348
  • [27] The platelet-to-lymphocyte ratio (PLR) versus Neutrophil-to-lymphocyte ratio (NLR) in prediction of Coronavirus disease-19 outcome
    Suliman, L.
    Elwasefy, M.
    Farrag, N. Saad
    Abdelwahab, H. Wagih
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [28] Platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) are associated with chronic hepatitis B virus (HBV) infection
    Zhao, Zhidan
    Liu, Jianhua
    Wang, Jiaxin
    Xie, Tinyan
    Zhang, Qiuhuan
    Feng, Sisi
    Deng, Hui
    Zhong, Baiyun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 51 : 1 - 8
  • [29] Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT)
    Hyder, J.
    Jang, H.
    Kim, S.
    Trinh, H.
    Chen, J.
    Flowers, J.
    Vaishampayan, N. G.
    Winer, I.
    Miller, S. R., II
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E663 - E664
  • [30] Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)
    Trinh, Hamilton
    Dzul, Stephen Paul
    Hyder, Jalal
    Jang, Hyejeong
    Kim, Seongho
    Flowers, Julianne
    Vaishampayan, Nitin
    Chen, Jerry
    Winer, Ira
    Miller, Steven
    CLINICA CHIMICA ACTA, 2020, 510 : 711 - 716